Cargando…
Management of the Axilla in the Era of Breast Cancer Heterogeneity
Systemic cancer therapies take into account breast cancer (BC) heterogeneity by targeting pathways specifically involved in some BC subtypes. On the other hand, BC intrinsic radiosensitivity is poorly understood and studied. Hence, radiotherapy personalization in BC is still “work in progress”. In t...
Autores principales: | de Meric de Bellefon, Maïlys, Lemanski, Claire, Ducteil, Angélique, Fenoglietto, Pascal, Azria, David, Bourgier, Celine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893721/ https://www.ncbi.nlm.nih.gov/pubmed/29670853 http://dx.doi.org/10.3389/fonc.2018.00084 |
Ejemplares similares
-
Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy
por: Prunaretty, Jessica, et al.
Publicado: (2023) -
Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients
por: Riou, Olivier, et al.
Publicado: (2015) -
Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management
por: Quesada, Stanislas, et al.
Publicado: (2022) -
Feasibility study of adaptive radiotherapy with Ethos for breast cancer
por: Galand, Arthur, et al.
Publicado: (2023) -
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator
por: Azria, David, et al.
Publicado: (2018)